Advanced search
Publication Cover
Drug and Alcohol Review Volume 21, 2002 - Issue 2
Journal homepage
14
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Substitution therapy for amphetamine users

James Shearer National Drug and Alcohol Research Centre, University of New South Wales, Australia
,
John Sherman Barkley Street Centre, Melbourne, Australia
,
Alex Wodak Drug and Alcohol Services, St Vincent's Hospital, Sydney, Australia
&
Ingrid van Beek Kirketon Road Centre, Sydney, Australia
Pages 179-185 | Published online: 12 Jul 2009

  • Pickering H, Stimson G. Prevalence and demographic factors of stimulant use. Addiction 1994; 89: 1385-89.
  • United Nations Office for Drug Control and Crime Prevention. World Drug Report 2000. Oxford: Oxford University Press, 2000.
  • Australian Bureau of Criminal Intelligence. Australian Illicit Drug Report 1999-2000. Canberra: Commonwealth of Australia, 2001.
  • Cho A. Ice: a new dosage form of an old drug. Science 1990;249:631-34.
  • Australian Institute of Health and Welfare. Statistics on drug use in Australia 1998. AIHW cat. no. PHE 16. Canberra: AIHW (Drug Statistics Series), 2000.
  • Baker A, Boggs T, Lewin T. Characteristics of regular amphetamine users and implications for treatment. Drug Alcohol Rev 2001;20:49-56.
  • Makkai T, McAllister I. Patterns of Drug Use in Australia 1985-95. Canberra: Commonwealth of Australia, 1998.
  • Topp L, Darke S, Bruno R, et al. Australian Drug Trends 2000; findings of the Illicit Drug Reporting System, monograph 47. Sydney: National Drug and Alcohol Research Centre, 2001.
  • Darke S, Topp L, Kaye S. Drug trends bulletin: December 2001. Sydney: Illicit Drug Reporting System, 2001.
  • Shand F, Mattick RP. Clients of treatment service agencies: May 2001 census findings. Canberra: AGPS, 2001.
  • White F, Kalivas P. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 1998;51:141-53.
  • Volkow N, Chang L, Wang G, et al. Association of dopamine transport reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001;! 58: 377-82.
  • Hando J, Topp L, HaIlW. Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia. Drug Alcohol Depend 1997;46: 105-13.
  • Anderson R, Flynn N. The methamphetamine-HIV connection in Northern California In: Klee, H. ed. Amphetamine misuse. Amsterdam: Harwood Academic Publishers, 1997;181-96.
  • Darke S, Kaue S, Ross J. Transitions between the injection of heroin and amphetamines. Addiction 1999;94: 1795-803.
  • Gossop M, Griffiths P, Powis B, Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict 1992;87:1527-36.
  • Klee H. A new target for behavioural research--amphetamine misuse. Br J Addict 1992;87:439-46.
  • Charnaud B, Griffiths V. Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison. Drug Alcohol Depend 1998;52:79-84.
  • Gowing L, Proudfoot H, Henry-Edwards S, Teesson M. Evidence supporting treatment: the effectiveness of interventions for illicit drug use. Canberra: Australian National Council on Drugs, 2001.
  • Platt J. Cocaine addiction: theory, research and treatment. Cambridge: Harvard University Press, 1997.
  • Crits-Christoph P, Siqueland L, Blaine J, et al Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry 1999;56:493-502.
  • Baker A, Boggs T, Lewin T. Randomised controlled trial of brief interventions among regular users of amphetamine Addiction 2001;96:1279-87.
  • De Lima M, Lima A, Scares B, Farrell M. A systematic review of pharmacological treatment of cocaine dependence. Geneva: World Health Organization, 2000.
  • JarvikM, Henningfield J. Pharmacological adjuncts for the treatment of tobacco dependence. In: Orleans, C, Slade, J. eds. Nicotine addiction: principles and management. New York: Oxford University Press, 1993:245-61.
  • Ward J, Mattick RP, Hall W. Methadone maintenance treatment and other opioid replacement therapies. Amsterdam: Harwood Academic Publishers, 1998.
  • Fleming PM. Prescribing amphetamine to amphetamine users as a harm reduction measure. Int J Drug Policy 1998;9:339-44.
  • Jaffe J. Drug addiction and drug abuse. In: Goodman LS, Oilman A's The pharmacological basis of therapeutics. New York: Pergamon, 1990:522-73.
  • Volkow N, Wang G, Fowler J, et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 1998;155:1325-31.
  • Volkow N, Wang G, Fowler J. Imaging studies of cocaine in the human brain and studies of the cocaine addict. Ann NY AcadSci 1997;820:41-55.
  • Volkow N, Wang G, Fischman M, et al. Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sci 67:1507-15.
  • Abreu M, Bigelow G, Fleisher L, Walsh S. Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans. Psychopharmacologia 2001; 154:76-84.
  • Hawks D, MitchesonM, Ogborne A, Edwards G. Abuse of methylamphetamine. Br Med J 1969;85:715-21.
  • Gardner R, Connell PH. Amphetamine and other nonopioid drug users attending a special drug dependence clinic. Br Med J 1972;2:322-25.
  • Kail K. Amphetamine abuse in Sweden. In: Klee H, ed. Amphetamine misuse. Amsterdam: Harwood Academic Publishers, 1997:215-233.
  • Bradbeer TM, Fleming PM, Charlton P, Crichton JS. Survey of amphetamine prescribing in England and Wales. Drug Alcohol Rev 1998;17:299-304.
  • Sherman JP. Dexamphetamine for 'speed' addiction. Med J Aust 1990;153:306.
  • Fleming PM, Roberts D. Is the prescription of amphetamine justified as a harm reduction measure? J R Soc Health 1994June:127-31.
  • Pates R, Coombes N, Ford N. A pilot programme in prescribing dexamphetamine for amphetamine users (part 1). J Subst Misuse 1996;l:80-4.
  • McBride AJ, Sullivan G, Blewett AE, Morgan S. Amphetamine prescribing as a harm reduction measure: a preliminary study. Addict Res 1997;5:95-112.
  • Klee H, Wright S, Carnwath T, Merrill J. The role of substitute therapy in the treatment of problem amphetamine use. Drug Alcohol Rev 2001;20:417-29.
  • Shearer J, Wodak A, Mattick RP, et al Pilot randomized controlled study of dexamphetamine for amphetamine dependence. Addiction 2001;96:1289-96.
  • White R. Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation. Addiction 2000;95:229-38.
  • Lintzeris N, Holgate F, Dunlop A. Addressing dependent amphetamine use: a place for prescription. Drug Alcohol Rev 1996;15:189-95.
  • Sato M, Chen C, Akiyama K, Otsuki S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry 1983;18:429-40.
  • StitzerM, Walsh S. Psychostimulant abuse: the case for combined behavioural and pharmacological treatments. Pharm Biochem Behav 1997;57:137-42.
  • Shearer J, Wodak A, van Beek I, Mattick RP, Lewis J. Randomised double blind placebo controlled study of dexamphetamine for cocaine dependence, (in preparation).
  • Grabowski J, Rhoades H, Schmitz JM, et al. Dextroamphetamine for cocaine-dependence treatment: a double blind randomised clinical trial. J Clin Psychopharmacol 2001;21:522-26.
  • Shearer J, Wodak A, Mattick RP, et al. A randomised controlled trial of the feasibility of monitoring controlled prescribing of dexamphetamine. Technical report no. 75 Sydney: National Drug and Alcohol Research Centre, 1999.
  • Tedow V, Merrill J. Rapid determination of amphetamine stereoisomer ratios in urine by gas chromatography-mass spectroscopy. Annal Clin Biochem 1996;33:50-4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.